UH performed the first case using the system Nov. 10. The Stealth Autoguide cranial robotic platform is designed for surgeries on adult and pediatric patients with neurological conditions. Using the platform, a surgeon can place an electrode or catheter in the brain or perform a biopsy with more precise movements while receiving continuous real-time visualization and feedback through the computer.
UH brain tumor and neuro-oncology center director Andrew Sloan, MD, said Medtronic chose the health system to begin using the tech because of its experience with laser interstitial thermal therapy, which is a technique used to treat primary and metastatic brain tumors that are hard to reach with conventional surgery.
More articles on health IT:
Former Cleveland Clinic CIO on retail competition: Hospitals must make digital changes or ‘become relic of the past’
States ranked by tech, science capabilities
COVID-19 vaccines must be accompanied by public education campaigns, experts say
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.